Study guide

15.2 USPTO Rules of Professional Conduct

USPTO Registration Examination Patent Bar

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview, Registration & MPEP Structure

1.1 Patent Bar Exam Format & Administration 1.2 Practitioner Qualifications & Eligibility 1.3 MPEP Structure & Effective Search Strategies

2 Chapter 2: Subject Matter Eligibility & Utility (35 U.S.C. § 101)

2.1 Patent-Eligible Subject Matter & Statutory Categories 2.2 Judicial Exceptions & the Alice/Mayo Framework 2.3 Utility Requirements & USPTO Utility Guidelines

3 Chapter 3: Novelty & Prior Art Under the AIA (35 U.S.C. § 102)

3.1 First-Inventor-to-File (FITF) & Effective Filing Dates 3.2 The One-Year Inventor Grace Period & Exceptions 3.3 Prior Art Types & Public Availability Standards

4 Chapter 4: Nonobviousness Analysis (35 U.S.C. § 103)

4.1 The Graham Factors & KSR Obviousness Framework 4.2 Combining Prior Art References & Motivation to Combine 4.3 Overcoming § 103 Rejections & Rule 132 Affidavits

5 Chapter 5: Specification & Disclosure Requirements (35 U.S.C. § 112(a))

5.1 Written Description Requirement 5.2 Enablement Requirement & Wands Factors 5.3 Best Mode Requirement & Current Post-AIA Status

6 Chapter 6: Claim Requirements & Definiteness (35 U.S.C. § 112(b)-(f))

6.1 Definiteness & Claim Precision 6.2 Independent & Dependent Claim Construction 6.3 Special Claim Formats: Means-Plus-Function & Markush Claims

7 Chapter 7: Application Types & Filing Procedures (MPEP Chapter 600)

7.1 Provisional Patent Applications 7.2 Nonprovisional Application Parts & Formalities 7.3 Inventor Oaths, Declarations & Assignments

8 Chapter 8: Duty of Disclosure & Information Disclosure Statements

8.1 Duty of Candor & Good Faith 8.2 Information Disclosure Statements (IDS) Requirements 8.3 Correcting Non-Disclosure & Duty Compliance

9 Chapter 9: Patent Prosecution & Office Action Responses (MPEP Chapter 700)

9.1 Initial Examination & Non-Final Office Actions 9.2 Statutory Deadlines & Extension of Time 9.3 Final Office Actions & Post-Final Practice

10 Chapter 10: Continuing Applications & Copendency

10.1 Continuation Applications 10.2 Divisional Applications 10.3 Continuation-in-Part (CIP) Applications & Priority Allocation

11 Chapter 11: Appeals & Interferences/Derivation (MPEP Chapter 1200 & 2300)

11.1 Ex Parte Appeals to the PTAB 11.2 PTAB Appeal Decisions & Judicial Review 11.3 Derivation Proceedings Under the AIA

12 Chapter 12: Post-Grant Proceedings & Corrections (MPEP Chapters 1400 & 2200)

12.1 Reissue Applications & Certificates of Correction 12.2 Ex Parte Reexamination & Supplemental Examination 12.3 Inter Partes Review (IPR) & Post-Grant Review (PGR)

13 Chapter 13: Patent Term, Maintenance Fees & Ownership

13.1 Patent Term Calculation & Patent Term Adjustment (PTA) 13.2 Maintenance Fees & Expiration 13.3 Inventorship, Ownership & Assignment Recordation 13.4 Patent Term Extension Under 35 U.S.C. § 156

14 Chapter 14: International Patent Practice & PCT (MPEP Chapter 1800)

14.1 The Patent Cooperation Treaty (PCT) Overview 14.2 PCT International Phase & Chapter I / Chapter II 14.3 National Phase Entry Under 35 U.S.C. § 371

15 Chapter 15: Special Patent Categories & Professional Conduct

15.1 Design Patents & Plant Patents 15.2 USPTO Rules of Professional Conduct 15.3 Patent Bar Exam Strategy & Open-Book Navigation Tips

16 Chapter 16: Security, Access, Representation & Filing Mechanics

16.1 Secrecy, Application Access & Foreign Filing Licenses 16.2 Representation, Power of Attorney & Correspondence 16.3 Filing Receipt, Certificates of Transmission & Signatures

17 Chapter 17: Restriction, Publication, Allowance & Office Authority

17.1 Restriction, Election, Rejoinder & Double Patenting 17.2 Publication, Preissuance Submissions & Protests 17.3 Allowance, Issue Fee & Withdrawal from Issue 17.4 Examiner Interviews, Petitions & Office Authority

18 Chapter 18: Biotechnology Disclosure & Patent Prosecution Highway

18.1 Biological Deposits & Sequence Listings 18.2 Global/IP5 Patent Prosecution Highway

19 Chapter 19: AIA Trial Practice Under the Consolidated Guide

19.1 AIA Trial Petitions, Preliminary Response & Institution 19.2 AIA Trial Discovery, Motions, Hearing & Final Decision

15.2 USPTO Rules of Professional Conduct

Key Takeaways Explain This Topic AI

Practitioner conduct before the USPTO is governed by 37 C.F.R. Part 11, which applies to both registered patent attorneys and registered patent agents.

Under 37 C.F.R. § 11.101, practitioners must provide competent representation, requiring the legal knowledge, skill, thoroughness, and scientific/technical preparation reasonably necessary for the representation.

Conflict of interest rules (§§ 11.107–11.109) prohibit representation directly adverse to another current client or representation materially limited by practitioner responsibilities, unless informed consent is confirmed in writing.

The Office of Enrollment and Discipline (OED) investigates grievances and enforces disciplinary sanctions (reprimand, probation, suspension, disbarment) within the earlier of 10 years after the misconduct or 1 year after it is reported to OED under 35 U.S.C. § 32.

Registered patent agents may practice before the USPTO and may prepare an assignment only as a reasonably necessary incident implementing pre-agreed terms; they may not negotiate general state-law contracts or conduct court litigation.

Last updated: August 2026

15.2 USPTO Rules of Professional Conduct

Administrative practice before the U.S. Patent and Trademark Office demands strict adherence to professional ethics. The USPTO Rules of Professional Conduct, codified at 37 C.F.R. Part 11 , govern the ethical duties of all registered patent attorneys, registered patent agents, and individuals granted limited recognition. The Patent Bar examination regularly tests Part 11 rules, focusing on conflicts of interest, competence, fee handling, duty of candor, Office of Enrollment and Discipline (OED) proceedings, and the boundaries of patent agent practice.

Framework of 37 C.F.R. Part 11

In 2013, the USPTO updated its professional conduct framework from the former Code of Professional Responsibility (37 C.F.R. Part 10) to the USPTO Rules of Professional Conduct (37 C.F.R. Part 11) , which closely mirror the American Bar Association (ABA) Model Rules of Professional Conduct. Part 11 applies to all matters before the Office, whether involving patent prosecution, trademark registration, or PTAB trial proceedings.

Practitioner Competence & Scope of Representation (§ 11.101)

Under 37 C.F.R. § 11.101 , a practitioner must provide competent representation to a client. Competent representation requires the legal knowledge, skill, thoroughness, and preparation reasonably necessary for the representation.

Key aspects tested on the exam include:

Technical Competence: Because patent prosecution requires understanding technical subject matter, a practitioner must not accept a case in an unfamiliar scientific discipline unless they can attain competence through reasonable preparation or association with a competent practitioner.

Scope of Representation (§ 11.102): A practitioner must abide by a client's decisions concerning the objectives of representation and must consult with the client as to the means by which they are to be pursued.

Diligence (§ 11.103): A practitioner must act with reasonable diligence and promptness in representing a client, avoiding unexcused delays that risk abandoning a patent application.

Conflict of Interest Rules (§§ 11.107–11.110)

Ethical conflicts of interest are among the most heavily tested ethics topics on the Patent Bar exam.

Current Client Conflicts (37 C.F.R. § 11.107)

A practitioner shall not represent a client if the representation involves a concurrent conflict of interest . A concurrent conflict exists if:

The representation of one client will be directly adverse to another client; or

There is a significant risk that representation of one or more clients will be materially limited by the practitioner's responsibilities to another client, a former client, a third person, or a personal interest of the practitioner.

Waiver Exception: A practitioner may represent a client despite a concurrent conflict ONLY if:

The practitioner reasonably believes they can provide competent and diligent representation to each affected client;

The representation is not prohibited by law;

The representation does not involve asserting a claim by one client against another represented by the practitioner in the same proceeding; and

Each affected client gives informed consent, confirmed in writing .

Former Client Conflicts (37 C.F.R. § 11.109)

A practitioner who has formerly represented a client in a matter shall not thereafter represent another person in the same or a substantially related matter in which that person's interests are materially adverse to the interests of the former client, unless the former client gives informed consent, confirmed in writing.

Imputed Disqualification (37 C.F.R. § 11.110)

While practitioners are associated in a firm, none of them shall knowingly represent a client when any one of them practicing alone would be prohibited from doing so under §§ 11.107 or 11.109, unless the prohibition is based on a personal interest or appropriate ethical screening ('ethical wall') is established.

Fee Agreements and Financial Safeguards (§§ 11.105 & 11.115)

Reasonable Fees (§ 11.105): A practitioner shall not make an agreement for, charge, or collect an unreasonable fee or unreasonable amount for expenses. Fee scope and basis must be communicated to the client, preferably in writing.

Safeguarding Property & Escrow Accounts (§ 11.115): Practitioners must keep client funds (such as advance fee retainers or official USPTO fee advances) in a separate client trust account maintained as Rule 11.115 requires. Commingling practitioner personal/firm funds with client trust funds is a severe ethical violation that leads to immediate OED investigation.

Duty of Candor and Honesty (§ 1.56 & § 11.303)

Practitioners owe an unyielding Duty of Candor and Good Faith to the USPTO:

Duty to Disclose Material Information (37 C.F.R. § 1.56): Every individual associated with the filing and prosecution of a patent application (including the practitioner) has a duty to disclose all information known to be material to patentability via an Information Disclosure Statement (IDS).

Candor Before the Tribunal (37 C.F.R. § 11.303): A practitioner shall not knowingly make a false statement of fact or law to the USPTO, fail to correct a material false statement, or offer evidence known to be false.

OED Oversight, Investigations, and Sanctions (§§ 11.32–11.60)

The Office of Enrollment and Discipline (OED) , headed by the OED Director, investigates practitioner misconduct and enforces compliance:

Grievances & Investigations (§ 11.32): The OED Director investigates possible violations of the Rules of Professional Conduct upon receipt of a grievance or credible information.

Probable Cause Panel (§ 11.36): If the OED Director believes a violation occurred, the matter is submitted to a Probable Cause Panel. Upon a finding of probable cause, a formal disciplinary complaint is filed.

Adjudication (§ 11.39): Formal disciplinary hearings are conducted before an Administrative Law Judge (ALJ).

Disciplinary Sanctions: Disciplinary penalties include: (a) Exclusion/Disbarment, (b) Suspension, (c) Public Reprimand, or (d) Probation.

Statute of Limitations (35 U.S.C. § 32): A disciplinary proceeding under 35 U.S.C. § 32 must be commenced not later than 10 years after the date on which the misconduct occurred , or 1 year from the date on which the misconduct is reported to the OED, whichever is earlier.

Unauthorized Practice of Law & Patent Agent Boundaries (§ 11.505)

Under 37 C.F.R. § 11.505 and the landmark Supreme Court decision Sperry v. State of Florida ex rel. Florida Bar (373 U.S. 379):

Registered Patent Agents: Non-attorney patent agents registered with the USPTO are federal administrative practitioners authorized to prepare, file, and prosecute patent applications before the USPTO. Federal law preempts state law regarding patent prosecution practice.

Prohibited Conduct for Patent Agents: Patent agents are NOT attorneys and cannot engage in the general practice of law. Agents are prohibited from:

Rendering legal advice on state-law matters such as trade-secret or licensing contracts, except for narrowly incidental assignment preparation permitted by federal USPTO-practice authority;

Preparing non-patent legal instruments (such as corporate organizational documents or litigation pleadings);

Representing clients in federal court litigation or state court proceedings.

Ethics Reference Matrix: 37 C.F.R. Part 11 Rules

  • Rule Section Topic Key Exam Requirement
  • 37 C.F.R. § 11.101 Competence Requires legal knowledge, technical skill, and thorough preparation
  • 37 C.F.R. § 11.105 Fees Fees must be reasonable; advance funds kept in client trust account

37 C.F.R. § 11.107 Current Conflicts Concurrent conflicts require reasonable belief of competence + written consent

37 C.F.R. § 11.109 Former Conflicts Substantially related matters with adverse interests require written consent

37 C.F.R. § 11.303 Candor to Tribunal Absolute prohibition against false statements or submission of false evidence

37 C.F.R. § 11.505 Unauthorized Practice Agents limited strictly to administrative patent prosecution before USPTO

Loading diagram... USPTO Office of Enrollment and Discipline (OED) Disciplinary Process